Format

Send to

Choose Destination
Vasc Endovascular Surg. 2013 May;47(4):278-80. doi: 10.1177/1538574413481117. Epub 2013 Mar 10.

Experience of HeRO dialysis graft placement in a challenging population.

Author information

1
The Mount Sinai Medical Center, New York, NY, USA.

Abstract

OBJECTIVE:

To assess the outcomes of the hemodialysis reliable outflow (HeRO) device in a subset of hemodialysis access-challenged patients with central venous obstruction.

METHODS:

Retrospective analysis of a series of patients in 2 centers who underwent placement of the HeRO device between September 2009 and November 2010. Patients' demographics, access history, HeRO patency, and number of reinterventions were analyzed.

RESULTS:

Eleven patients underwent 12 HeRO implantations. The average duration of dialysis prior to HeRO placement was 5.55 ± 3.64 years. Primary and secondary patencies at 6 months and 1 year were 36.4% and 54.5% and 9.1% and 45.5%, respectively.

CONCLUSIONS:

In the end-stage renal disease population with central venous occlusive disease, the HeRO device offers the best long-term dialysis option when an arteriovenous fistula or graft is not possible. Close follow-up and subsequent aggressive interventions can prolong the use of the HeRO and avoid the last resort of dialysis catheters.

KEYWORDS:

HeRO; arteriovenous graft; central venous obstruction; central venous occlusion; hemodialysis

PMID:
23478878
DOI:
10.1177/1538574413481117
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center